William Allen Freed-Pastor, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mevalonic Acid | 3 | 2018 | 45 | 1.070 |
Why?
|
| Tumor Suppressor Protein p53 | 8 | 2018 | 2942 | 1.020 |
Why?
|
| Receptors, Virus | 1 | 2021 | 651 | 0.580 |
Why?
|
| Immune Evasion | 1 | 2021 | 377 | 0.580 |
Why?
|
| Oncogenes | 1 | 2022 | 1235 | 0.530 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1106 | 0.490 |
Why?
|
| Pancreatic Neoplasms | 6 | 2023 | 5444 | 0.460 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 1761 | 0.460 |
Why?
|
| Mutant Proteins | 1 | 2012 | 488 | 0.340 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2022 | 1758 | 0.290 |
Why?
|
| DNA | 3 | 2018 | 7202 | 0.250 |
Why?
|
| Immunotherapy | 1 | 2021 | 4752 | 0.250 |
Why?
|
| Haptens | 1 | 2022 | 163 | 0.200 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2021 | 72 | 0.180 |
Why?
|
| Apoptosis | 2 | 2016 | 9514 | 0.180 |
Why?
|
| DNA Footprinting | 1 | 2018 | 97 | 0.150 |
Why?
|
| Mutation | 5 | 2023 | 30196 | 0.130 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2021 | 451 | 0.130 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2021 | 950 | 0.120 |
Why?
|
| Neoplasms | 4 | 2022 | 22340 | 0.120 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 2002 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 548 | 0.100 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2012 | 25 | 0.100 |
Why?
|
| Prenylation | 1 | 2012 | 36 | 0.100 |
Why?
|
| Epigenomics | 1 | 2017 | 959 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 4642 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 632 | 0.090 |
Why?
|
| Peptides | 1 | 2022 | 4331 | 0.090 |
Why?
|
| Dendritic Cells | 1 | 2021 | 2747 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3454 | 0.080 |
Why?
|
| Simvastatin | 1 | 2012 | 345 | 0.080 |
Why?
|
| Lung Neoplasms | 3 | 2022 | 13451 | 0.080 |
Why?
|
| Proteomics | 1 | 2022 | 3910 | 0.080 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 21056 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 3 | 2018 | 5786 | 0.080 |
Why?
|
| Mice | 7 | 2023 | 81818 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 798 | 0.070 |
Why?
|
| Animals | 9 | 2023 | 168759 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2022 | 6364 | 0.060 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 17075 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 3819 | 0.050 |
Why?
|
| Humans | 16 | 2023 | 765956 | 0.050 |
Why?
|
| Serine | 1 | 2007 | 824 | 0.050 |
Why?
|
| Transcription Factors | 3 | 2018 | 12131 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2017 | 4424 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5389 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 2 | 2022 | 2895 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 9601 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2021 | 369 | 0.040 |
Why?
|
| Protein Binding | 3 | 2018 | 9296 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 4520 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 9550 | 0.040 |
Why?
|
| Genes, ras | 1 | 2022 | 658 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 8611 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2018 | 3946 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2018 | 58 | 0.040 |
Why?
|
| Terpenes | 1 | 2018 | 102 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 7599 | 0.040 |
Why?
|
| Binding Sites | 2 | 2018 | 6001 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 399 | 0.040 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2018 | 295 | 0.040 |
Why?
|
| Cell Line | 2 | 2023 | 15543 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3251 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2022 | 1250 | 0.030 |
Why?
|
| Models, Biological | 1 | 2012 | 9443 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2022 | 1365 | 0.030 |
Why?
|
| Gene Library | 1 | 2018 | 1067 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2015 | 187 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 3750 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2021 | 1297 | 0.030 |
Why?
|
| Phylogeny | 1 | 2022 | 2832 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 1061 | 0.030 |
Why?
|
| Kinetics | 1 | 2021 | 6274 | 0.030 |
Why?
|
| Propensity Score | 1 | 2021 | 1968 | 0.030 |
Why?
|
| Response Elements | 1 | 2015 | 307 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 1811 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22331 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2018 | 1247 | 0.020 |
Why?
|
| Nucleosomes | 1 | 2015 | 494 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 1365 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 4893 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2015 | 1495 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 722 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2536 | 0.020 |
Why?
|
| Cholesterol | 1 | 2018 | 2898 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3946 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2018 | 1697 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 2428 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 6493 | 0.020 |
Why?
|
| Ligands | 1 | 2015 | 3273 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2018 | 5379 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2022 | 12769 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2022 | 9524 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2007 | 541 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14447 | 0.020 |
Why?
|
| Liver | 1 | 2018 | 7562 | 0.010 |
Why?
|
| Cell Separation | 1 | 2007 | 1718 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11868 | 0.010 |
Why?
|
| Prognosis | 1 | 2022 | 29921 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 1314 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 2194 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 11888 | 0.010 |
Why?
|
| Female | 2 | 2018 | 396101 | 0.010 |
Why?
|
| DNA Damage | 1 | 2007 | 2457 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2007 | 5881 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2007 | 8278 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 13400 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 17594 | 0.010 |
Why?
|
| Male | 1 | 2018 | 363691 | 0.000 |
Why?
|